NasdaqGS:SGRYHealthcare
Assessing Surgery Partners (SGRY) Valuation After Activist Pressure And Mixed Earnings Updates
Why Surgery Partners stock is back in focus
Surgery Partners (SGRY) is back under the spotlight after activist investor Ortelius Advisors issued a sharp public letter calling for asset sales, leadership changes, and a broad review of the company’s direction.
The critique lands just after softer full-year guidance, a weaker Q4 showing, fresh analyst revisions, insider share sales, and the acquisition of Preferred Vascular Group, giving investors several moving parts to weigh at once.
See our...